Mesoblast set to line up another FDA chat
MELBOURNE: Shares in stem cell treatments developer Mesoblast opened 3 per cent higher this morning
MELBOURNE: Shares in stem cell treatments developer Mesoblast opened 3 per cent higher this morning
FEATURED
Assisted living providers learn strategies to tackle staffing challenges
Former hospital now set to be slated for senior housing
Wealthy downsizers flock to hotel-style units in inner suburbs
‘Smart socks’ could help millions living with dementia
Scheme allows care providers to make ‘virtual visits’ to innovation hubs
Retirees are now living best lives in off-shore choice locations
INNOVATION
